Table 2.3.12.1
Dopamine agonist trials in patients with clinically non-functioning pituitary adenomas
Visual fields Tumour volume Drug Reference
Improved Stable Worsened Growth Stable Shrinkage

0/11

2/11

9/11

Bromocriptine

85

0/12

6/12

6/12

Bromocriptine

86

0/15

15/15

0/15

Bromocriptine/mesulergine/pergolide

87

1/5

4/5

0/5

0/5

1/5

4/5

Bromocriptine

88

1/20

15/20

4/20

0/20

19/20

1/20

Bromocriptine

89

0/7

7/7

0/7

Bromocriptine

90

3/3

0/3

0/3

Bromocriptine

91

0/8

8/8

0/8

Bromocriptine

92

0/4

2/4

2/4

Bromocriptine

93

1/25

23/25

1/25

1/25

20/25

4/25

Bromocriptine

95

2/5

3/5

0/5

0/5

4/5

1/5

Quinagolide

96

0/6

4/6

2/6

Quinagolide

97

0/10

6/10

4/10

6/10

4/10

0/10

Quinagolide

99

3/10

7/10

0/10

0/10

8/10

2/10

Quinagolide/cabergoline

98

2/13

11/13

0/13

0/13

6/13

7/13

Cabergoline

100

4/9

5/9

0/9

3/9

1/9

5/9

Cabergoline

82

7/33

15/33

11/33

Bromocriptine

101

17/100

74/100

9/100

17/193

122/193

54/193

Overall

17%

74%

9%

9%

63%

28%

Visual fields Tumour volume Drug Reference
Improved Stable Worsened Growth Stable Shrinkage

0/11

2/11

9/11

Bromocriptine

85

0/12

6/12

6/12

Bromocriptine

86

0/15

15/15

0/15

Bromocriptine/mesulergine/pergolide

87

1/5

4/5

0/5

0/5

1/5

4/5

Bromocriptine

88

1/20

15/20

4/20

0/20

19/20

1/20

Bromocriptine

89

0/7

7/7

0/7

Bromocriptine

90

3/3

0/3

0/3

Bromocriptine

91

0/8

8/8

0/8

Bromocriptine

92

0/4

2/4

2/4

Bromocriptine

93

1/25

23/25

1/25

1/25

20/25

4/25

Bromocriptine

95

2/5

3/5

0/5

0/5

4/5

1/5

Quinagolide

96

0/6

4/6

2/6

Quinagolide

97

0/10

6/10

4/10

6/10

4/10

0/10

Quinagolide

99

3/10

7/10

0/10

0/10

8/10

2/10

Quinagolide/cabergoline

98

2/13

11/13

0/13

0/13

6/13

7/13

Cabergoline

100

4/9

5/9

0/9

3/9

1/9

5/9

Cabergoline

82

7/33

15/33

11/33

Bromocriptine

101

17/100

74/100

9/100

17/193

122/193

54/193

Overall

17%

74%

9%

9%

63%

28%

Modified from Colao A, Di Somma C, Pivonello R, Faggiano A, Lombardi G, Savastano S. Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer, 2008; 15: 905–15. (1).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close